Literature DB >> 16736444

Metabolic and clinical consequences of metabolic acidosis.

W E Mitch1.   

Abstract

Acid-base balance is precisely regulated by pulmonary and renal responses while body buffers help to control pH. When its regulation becomes abnormal, accumulation of hydrogen ions cause metabolic acidosis and several responses are activated. These responses interfere with the metabolism of bones and muscle. Metabolic acidosis induces abnormalities in the release and function of several hormones including defects in growth hormone, IGF-1, insulin, glucocorticoids, thyroid hormone, parathyroid hormone and vitamin D. Clinical consequences of these abnormal metabolic responses include impaired growth of infants and children and loss of bone and muscle mass in adults. Notably, abnormalities in bone and muscle metabolism can be present even when there is little or no decrease in the plasma bicarbonate concentration. The abnormalities can be corrected by treatment with NaHCO 3 . In patients with chronic kidney disease, many abnormalities in bone and muscle metabolism can be directly linked to the presence of metabolic acidosis and these abnormalities can be largely corrected by treating acidosis with NaHCO3. Recent insights indicate that several consequences of metabolic acidosis including the development of insulin resistance can stimulate muscle protein degradation by activating proteolytic mechanisms. To avoid abnormalities in metabolism and the loss of bone and muscle, metabolic acidosis must be corrected in normal adults and in patients with kidney disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736444

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  23 in total

Review 1.  Ammonia Transporters and Their Role in Acid-Base Balance.

Authors:  I David Weiner; Jill W Verlander
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 2.  Low-protein diet for diabetic nephropathy.

Authors:  Toshiki Otoda; Keizo Kanasaki; Daisuke Koya
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 3.  Acid-base regulation in the renal proximal tubules: using novel pH sensors to maintain homeostasis.

Authors:  Premraj Rajkumar; Jennifer L Pluznick
Journal:  Am J Physiol Renal Physiol       Date:  2018-08-01

Review 4.  Roles of renal ammonia metabolism other than in acid-base homeostasis.

Authors:  I David Weiner
Journal:  Pediatr Nephrol       Date:  2016-05-12       Impact factor: 3.714

Review 5.  Pharmacologically-induced metabolic acidosis: a review.

Authors:  George Liamis; Haralampos J Milionis; Moses Elisaf
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

6.  Risk of fracture after radical cystectomy and urinary diversion for bladder cancer.

Authors:  Amit Gupta; Coral L Atoria; Behfar Ehdaie; Shahrokh F Shariat; Farhang Rabbani; Harry W Herr; Bernard H Bochner; Elena B Elkin
Journal:  J Clin Oncol       Date:  2014-09-02       Impact factor: 44.544

Review 7.  Nutrition aspects in children receiving maintenance hemodialysis: impact on outcome.

Authors:  Poyyapakkam R Srivaths; Craig Wong; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2008-02-22       Impact factor: 3.714

8.  Combined walking exercise and alkali therapy in patients with CKD4-5 regulates intramuscular free amino acid pools and ubiquitin E3 ligase expression.

Authors:  Emma L Watson; George C Kosmadakis; Alice C Smith; Joao L Viana; Jeremy R Brown; Karen Molyneux; Izabella Z A Pawluczyk; Michael Mulheran; Nicolette C Bishop; Susan Shirreffs; Ronald J Maughan; Paul J Owen; Stephen G John; Christopher W McIntyre; John Feehally; Alan Bevington
Journal:  Eur J Appl Physiol       Date:  2013-04-17       Impact factor: 3.078

9.  Double osteomalacia.

Authors:  Kamal Kishore Pandita; Khalid Javed Bhat; Tanveer Hassan Banday
Journal:  Clin Cases Miner Bone Metab       Date:  2012-12-20

Review 10.  Recent advances in understanding renal ammonia metabolism and transport.

Authors:  I David Weiner; Jill W Verlander
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-09       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.